Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

PPF Group

Founders Petr Kellner

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 22
Average round size
info
The average size of a deal this fund participated in
$54M
Portfolio companies 12
Rounds per year 0.69
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.45
Exits 5
Key employees 9

Areas of investment

  • Biotechnology
  • Therapeutics
  • Health Care
  • Medical
  • Biopharma
Summary

In 1991 was created PPF Group, which is appeared as VC. The leading representative office of defined VC is situated in the Amsterdam. The venture was found in Europe in The Netherlands.

We can highlight the next thriving fund investment areas, such as Media and Entertainment, Content. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. For fund there is no match between the location of its establishment and the land of its numerous investments - Switzerland. Among the most popular portfolio startups of the fund, we may highlight Culture Trip, MaveriX Oncology, CytunePharma.

This organization was formed by Petr Kellner.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the PPF Group, startups are often financed by GoBeyond, Boehringer Ingelheim Venture Fund, Pierre Barbe. The meaningful sponsors for the fund in investment in the same round are FC Capital, Boehringer Ingelheim Venture Fund, Partners Investment. In the next rounds fund is usually obtained by Novo Holdings, GoBeyond, Future Fifty.

Considering the real fund results, this VC is 50 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2018. The fund is constantly included in 2-6 investment rounds annually. This PPF Group works on 9 percentage points less the average amount of lead investments comparing to the other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
BankInvest Copenhagen, Denmark, Hovedstaden
Bhoruka Finance -
Bradley Family Trust Milwaukee, United States, Wisconsin
Capture Investments -
Centuria Ventures Arkansas, Fort Smith, United States
Dahua Technology Binjiang, China, Jiangxi
Emerging Growth Management -
Footpath Ventures New York, New York, United States
Footprint Ventures Bangalore, India, Karnataka
HC2 Herndon, United States, Virginia
Hitotoki Incubator Chiba, Japan, Minato
Innovation Factory (Canada) Canada, Hamilton, Ontario
Innovation Ulster Newtownabbey, Northern Ireland, United Kingdom
Malin Corporation County Dublin, Dublin, Ireland
MTM Missouri, St Louis, United States
Raine Ventures California, San Francisco, United States
SAIC Venture Capital Las Vegas, Nevada, United States
Taijing Touzi Beijing, Beijing, China
TOTVS Brazil, São Paulo, Sao Paulo

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Culture Trip

Communities
Content
Media and Entertainment
News
Social Media
$46M25 Aug 2020 London, England, United Kingdom

NBE-Therapeutics

Biotechnology
Health Care
Medical
Therapeutics
$22M10 Jan 2020 Basel, Basel-City, Switzerland

Cellestia Biotech

Biopharma
Biotechnology
Health Care
Therapeutics
$21M17 Dec 2019 Lausanne, Vaud, Switzerland

MaveriX Oncology

Biotechnology
Therapeutics
$6M14 Oct 2019 Palo Alto, California, United States

Cellestia Biotech

Biopharma
Biotechnology
Health Care
Therapeutics
$21M19 Dec 2018 Lausanne, Vaud, Switzerland

NBE-Therapeutics

Biotechnology
Health Care
Medical
Therapeutics
$21M28 Jun 2018 Basel, Basel-City, Switzerland

Culture Trip

Communities
Content
Media and Entertainment
News
Social Media
$116M24 Apr 2018 London, England, United Kingdom

Cellestia Biotech

Biopharma
Biotechnology
Health Care
Therapeutics
$8M26 Jan 2017 Lausanne, Vaud, Switzerland

NBE-Therapeutics

Biotechnology
Health Care
Medical
Therapeutics
$21M03 Nov 2016 Basel, Basel-City, Switzerland

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent PPF Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 22
Average round size 54M
Rounds per year 0.69
Peak activity year 2019
Lead investments 6
Follow on index 0.45
Exits 5
Group Appearance index 0.50

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Culture Trip

Communities
Content
Media and Entertainment
News
Social Media
$46M25 Aug 2020 London, England, United Kingdom

NBE-Therapeutics

Biotechnology
Health Care
Medical
Therapeutics
$22M10 Jan 2020 Basel, Basel-City, Switzerland

Cellestia Biotech

Biopharma
Biotechnology
Health Care
Therapeutics
$21M17 Dec 2019 Lausanne, Vaud, Switzerland

MaveriX Oncology

Biotechnology
Therapeutics
$6M14 Oct 2019 Palo Alto, California, United States

Cellestia Biotech

Biopharma
Biotechnology
Health Care
Therapeutics
$21M19 Dec 2018 Lausanne, Vaud, Switzerland

NBE-Therapeutics

Biotechnology
Health Care
Medical
Therapeutics
$21M28 Jun 2018 Basel, Basel-City, Switzerland

Culture Trip

Communities
Content
Media and Entertainment
News
Social Media
$116M24 Apr 2018 London, England, United Kingdom

Cellestia Biotech

Biopharma
Biotechnology
Health Care
Therapeutics
$8M26 Jan 2017 Lausanne, Vaud, Switzerland

NBE-Therapeutics

Biotechnology
Health Care
Medical
Therapeutics
$21M03 Nov 2016 Basel, Basel-City, Switzerland
Crunchbase icon

Content report

The following text will be sent to our editors: